A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the US

INTRODUCTION: Sugammadex rapidly reverses the effects of rocuronium- and vecuronium-induced neuromuscular blockade (NMB), offering a more complete and predictable NMB recovery than cholinesterase inhibitors. Despite clinical benefits, cost pressures on hospital budgets influence the choice of the NM...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yiling, Bash, Lori D., Saager, Leif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107065/
https://www.ncbi.nlm.nih.gov/pubmed/33871823
http://dx.doi.org/10.1007/s12325-021-01701-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107065/
https://www.ncbi.nlm.nih.gov/pubmed/33871823
http://dx.doi.org/10.1007/s12325-021-01701-1

Ejemplares similares